Features & Benefits
- Broad Coverage:
Utilizes more than 200 antibodies to develop 3-D conformational fingerprint.
- Intelligent Database:
Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints.
- Artificial Intelligence Driven Data Analysis
- Glycan Profiling
- Predictive of Functional Activities:
- Target binding
- ADCC and CDC activity
- Fc Receptor binding
Intelli.b – Biosimilar Fingerprinting Technology
Somru BioScience has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).
Application of Intelli.b
Harness power of laboratory automation to boost your drug development studies.
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
A comprehensive bioanalytical solution
Somru developed the following comprehensive list of bioanalytical assays to support..
Read More ...Recommendations on ELISpot assay
Gene therapy, cell therapy and vaccine research have led to..
Read More ...Pharmacokinetic Assays
Pharmacokinetic Assays Solutions Method Development Reagent development DOE driven method..
Read More ...biosimilarwatch
We’re busy creating something exciting for you! This page is..
Read More ...